Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes-Reference-Cited by-同舟云学术

Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes

Published:2018-10 Issue: Volume:277 Page:72-79
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Muñoz-Hernandez Liliana,Ortiz-Bautista Raul J.,Brito-Córdova Griselda,Lozano-Arvizu Francisco,Saucedo Sharim,Pérez-Méndez Oscar,Zentella-Dehesa Alejandro,Dauteuille Carolane,Lhomme Marie,Lesnik Philippe,Chapman M.John,Kontush Anatol,Aguilar Salinas Carlos A.

Funder

Instituto Nacional de Ciencias Médicas y Nutrición Salvador

National Institute for Health and Medical Research

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference56 articles.

1. Glycation impairs high-density lipoprotein function;Hedrick;Diabetologia,2000

2. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins;Borggreve;Eur. J. Clin. Invest.,2003

3. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia;Nobécourt;Diabetologia,2005

4. Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation;Perségol;Diabetologia,2006

5. Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus;Nieuwdorp;Diabetologia,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDL abnormalities in type 2 diabetes: Clinical implications;Atherosclerosis;2023-08

2. High density lipoprotein as a therapeutic target: Focus on its functionality;BIOCELL;2023

3. Hypercholesterolemia-Induced HDL Dysfunction Can Be Reversed: The Impact of Diet and Statin Treatment in a Preclinical Animal Model;International Journal of Molecular Sciences;2022-08-02

4. Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol‐lowering treatments?;European Journal of Clinical Investigation;2022-03-24

5. The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity;Atherosclerosis;2022-03